MURDOCK Study now part of Duke CTSI

Duke’s Kannapolis office and the MURDOCK Study are proud to be part of the new Duke Clinical & Translational Science Institute (CTSI), an academic hub for accelerating the translation and implementation of scientific discoveries into health benefits for patients and communities.
L. Kristin Newby, MD, MHS, principal investigator for the MURDOCK Study, is the faculty lead for the CTSI’s Translational Population Health Research Group. The CTSI strives to overcome the obstacles to developing discoveries into devices, drugs, or therapies to improve health. The CTSI collaborates with schools, departments, denters and programs across Duke. To learn more about the CTSI, click here.